RANI · ISSUER CIK 1856725
Rani Therapeutics Holdings, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Rani Therapeutics Holdings, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202616:42 | Sep 27, 2026 | RANI | Chief Executive Officer, Director | F · Tax | $0.76 | −7,928 | 461,808 | -2% | $6K | ||
| Sep 29, 202616:36 | Sep 27, 2026 | RANI | Chief Technical Officer | F · Tax | $0.76 | −309 | 9,071 | -3% | $234.59 |